Aβ42-IN-7
Aβ42-IN-7 (Compound CT-01) is a brain-penetrant and selective amyloid-β42 (Aβ42) inhibitor. Aβ42-IN-7 inhibits Aβ42’s assembly into neurotoxic soluble oligomers and extracellular fibrillary aggregates. Aβ42-IN-7 exerts neuroprotective effects by reducing amyloid-mediated neuronal toxicity. Aβ42-IN-7 can be used in research on Alzheimer’s disease (AD) [1].
Product Specifications
UNSPSC
12352005
Target
Amyloid-β
Related Pathways
Neuronal Signaling
Field of Research
Neurological Disease
Smiles
BrC1=CC=C(N(CCCN2C(C(N(C)C(N3C)=O)=O)=C3N=C2)C4=C5C=C(Br)C=C4)C5=C1
Molecular Formula
C22H19Br2N5O2
Molecular Weight
545.23
References & Citations
[1]Gharai PK, et al. Discovery of Carbazole and Theophylline-Based Amyloid Inhibitor for the Promotion of Neuroprotection. ACS Chem Neurosci. 2025 Jun 18;16 (12) :2224-2236.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUM1696-50 1x 50 µL
CTLA4 / CD152 (Negative Regulator of T-Cells) (L4P2F5.F10), 1mg/mL
Sign In for Pricing
View Details 
